Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical mitomycin for relapsed nasal polyposis after endoscopic sinus surgery
IRCT20200810048356N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mitomycin c in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Kashan University of Medical Sciences. Primary endpoint: Recurrence of nasal polyps. Started Jul 2020; status: completed.
02
Drugs
mitomycin c
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20200810048356N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200810048356N1.